NHS Healthier You

{
  "id": "044099-2026",
  "tag": [
    "tenderUpdate"
  ],
  "date": "2026-05-13T16:17:30+01:00",
  "ocid": "ocds-h6vhtk-060669",
  "buyer": {
    "id": "GB-FTS-178030",
    "name": "NHS England"
  },
  "tender": {
    "id": "C415740",
    "title": "NHS Healthier You",
    "amendments": [
      {
        "id": "1",
        "unstructuredChanges": [
          {
            "where": {
              "section": "IV.2.2.1"
            },
            "newValue": {
              "date": "2026-06-12T12:00:00+01:00"
            },
            "oldValue": {
              "date": "2026-06-05"
            }
          }
        ]
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "The Contracting Authority is procuring the NHS Healthier You Programme utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023. This competitive provider selection process has multiple gateways as described in this notice.<br/><br/>The NHS Healthier You Programme procurement comprises of the following:<br/>• NHS Healthier You Behavioural Support for Obesity Prescribing (\"BSOP) Service\"): Targeted support for individuals prescribed pharmacotherapy GLP-1 medications as approved in a Primary Care setting by NICE. Service Users provided with the BSOP Service are referred to as the \"BSOP Cohort\".<br/>• NHS Healthier You Diabetes Prevention Programme (\"DPP Service\"): Support for individuals identified as at high risk of developing type 2 diabetes. Service Users provided with the DPP Service are referred to as the \"DPP Cohort\".<br/>• NHS Healthier You Type 2 Diabetes Path to Remission (\"T2DR Service\"): Support for individuals diagnosed with type 2 diabetes within the last 6 years and living with overweight or obesity. Service Users provided with the T2DR Service are referred to as the \"T2DR Cohort\".<br/>• NHS Healthier You Long Term Conditions Prevention Pilot (\"LTCP Service\"): Support for individuals diagnosed with hypertension. Service Users provided with the LTCP Service are referred to as the \"LTCP Cohort\".<br/><br/>The Contracting Authority has divided this opportunity into 26 ICB/ICB Clusters. ICB Clusters are groupings of ICBs. The complete list is set out in VI.3.<br/><br/>Bidders will need the capability and capacity to provide the full suite of services to an ICB/ICB Cluster, offering eligible participants a choice of group based in-person services or a digitally delivered, independently accessed service provided through a web browser or a mobile application. The Type 2 diabetes Path to Remission intervention will only be delivered on a one-to-one basis (delivered in-person or remotely).<br/><br/>Contracts will be awarded by Supplier. Bidders can be awarded a contract for more than one ICB/ICB Cluster. In such instances, one contract would be issued to the Supplier listing the ICB's/ICB Clusters awarded. This means a maximum of 26 contracts may be awarded in the event a different Supplier is awarded for each ICB/ICB Cluster.<br/><br/>The anticipated value across the ICB's/ICB Clusters is £386,000,000 excluding VAT. This is based on the initial term of 36 months. There will be an option to extend by up to 24 months, giving a maximum term of 60 months. The anticipated value of the 60 month term is £738,000,000 excluding VAT. VAT will be applied as appropriate.<br/><br/>The estimated date of mobilisation / service commencement will be from 1 November 2026.",
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-178030",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKE42",
        "locality": "Leeds",
        "postalCode": "LS1 4AP",
        "countryName": "United Kingdom",
        "streetAddress": "7 & 8 Wellington Place"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "buyerProfile": "https://www.england.nhs.uk/"
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "name": "Leigh Parker",
        "email": "leigh.parker1@nhs.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}

{
  "id": "033470-2026",
  "tag": [
    "tender"
  ],
  "date": "2026-04-13T17:32:44+01:00",
  "ocid": "ocds-h6vhtk-060669",
  "buyer": {
    "id": "GB-FTS-107961",
    "name": "NHS England"
  },
  "tender": {
    "id": "C415740",
    "lots": [
      {
        "id": "1",
        "value": {
          "amount": 738000000,
          "currency": "GBP"
        },
        "status": "active",
        "options": {
          "description": "An option to extend of up to a maximum of 24 months."
        },
        "hasOptions": true,
        "hasRenewal": false,
        "description": "As part of this process, the Contracting Authority would like to invite interested parties to read and complete our Invitation to Tender within our e-Tendering System Atamis, https://atamis-1928.my.site.com/s/Welcome. This service will be competed under The Health Care Services (Provider Selection Regime) Regulations 2023 and will not be competed via Public Contract Regulations 2015 or via the Procurement Act 2023.<br/><br/>The Contracting Authority will be using Atamis, the Contracting Authority’s e-Tendering system for this procurement exercise. For further information, the ITT documentation can be found via the 'Live Opportunities' list on the e-tendering system. <br/><br/>The procurement will be assessed through a multi-stage approach as follows:<br/><br/>Stage 1 (Compliance and Supplier Information Questionnaire)<br/>Compliance checks will be completed to ensure tenders are completed as per the ITT instructions. The Suppler Information Questionnaire will evaluate the Basic Selection Criteria. The questions will be evaluated on a Pass/Fail or for information only basis and can be found in Document 3. <br/><br/>Stage 2 (Quality and Commercial Envelope)<br/>This will be the evaluation of the Quality and Commercial envelope which contains the Key Criteria questions and can be found in Document 4 (Quality Envelope) and Document 5 (Commercial Envelope). Scores from Stage 2 evaluation will form 40% of the final score at Stage 3 evaluation.<br/><br/>Stage 3 (ICB/ICB Cluster Quality Envelope)<br/>This envelope will be evaluated to identify the Bidders who best meet the Contracting Authority’s key criteria for delivery of the Requirements in each ICB/ICB Cluster. Scores from Stage 3 evaluation will form 60% of the final score at Stage 3 evaluation. The scores from Stage 2 and Stage 3 evaluation will be combined to determine the successful Bidder per ICB/ICB Cluster.<br/><br/>The Key Criteria (as outlined in PSR Regulation 5) for Stage 2 & Stage 3 will be evaluated as outlined below:<br/><br/>Stage 2 - Quality Envelope - 60%<br/><br/>1) Managing Referrals and Offering a Choice of Delivery Modes – 6%<br/>Key Criteria Assessed: <br/>(a) Quality and Innovation<br/>(d) Improving Access, Reducing Health Inequalities and Facilitating Choice <br/><br/>2) In-Person and Remote Delivery Modes: Approach to Delivery – 5%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>3) In-Person and Remote Delivery Modes: Service Design, Schedule and Content - 4%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>4) Digital Delivery Mode: Approach to Delivery - 5%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/> <br/>5) Digital Delivery Mode: Service Design, Schedule and Content - 4%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>6) Behaviour Change Approach and Logic Model - 6%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>7) Integration of TDR Products and Monitoring Equipment in the T2DR Service Model - 3%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/>(d) Improving Access, Reducing Health Inequalities and Facilitating Choice <br/><br/>8) Mobilisation - 5%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>9) Workforce Competency and Training - 4%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>10) Management and Quality of Data - 4%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>11) Quality Assurance and Governance - 4%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/><br/>12) Social Value: Employment and training for those who face barriers to employment - 10%<br/>Key Criteria Assessed:<br/>(e) Social Value<br/><br/>Stage 2 - Commercial Envelope - 40%<br/><br/>Key Criteria Assessed:<br/>(b) Value<br/><br/>Stage 3 – ICB/ ICB Cluster Quality Envelope - 60%<br/><br/>1) Local Integration – 30%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/>(d) Improving Access, Reducing Health Inequalities and Facilitating Choice<br/><br/>2) Meeting Local Need, Reducing Health Inequalities and Tailoring to Underrepresented Populations – 30%<br/>Key Criteria Assessed:<br/>(a) Quality and Innovation<br/>(c) Integration, Collaboration and Service Sustainability<br/>(d) Improving Access, Reducing Health Inequalities and Facilitating Choice <br/><br/>Scores from Stage 2 evaluation will form 40% of the final score.<br/><br/>Only bids which pass compliance checks and the Basic Selection Criteria Questionnaire in accordance with the Document 1 - ITT Instructions and Document 3 – Basic Selection Criteria Questionnaire will proceed to Stage 2. <br/><br/>Up to 5 Bidders per ICB/ICB Cluster with the highest combined score from Stage 2 who also meet the relevant minimum scoring thresholds will have their response(s) to the Stage 3 ICB/ICB Cluster Quality Envelope(s) evaluated. <br/><br/>For each ICB/ICB Cluster the Bidder with the highest scoring Bid after the scores at Stage 2 and Stage 3 have been combined will be the preferred Bidder for that ICB/ICB Cluster. <br/><br/>Contracts will be awarded to all successful Suppliers, listing the ICB(s)/ICB Cluster(s) they will be delivering services to.",
        "contractPeriod": {
          "durationInDays": 1080
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          },
          {
            "id": "75200000",
            "scheme": "CPV",
            "description": "Provision of services to the community"
          },
          {
            "id": "85140000",
            "scheme": "CPV",
            "description": "Miscellaneous health services"
          },
          {
            "id": "85312310",
            "scheme": "CPV",
            "description": "Guidance services"
          },
          {
            "id": "85323000",
            "scheme": "CPV",
            "description": "Community health services"
          },
          {
            "id": "85312320",
            "scheme": "CPV",
            "description": "Counselling services"
          },
          {
            "id": "98000000",
            "scheme": "CPV",
            "description": "Other community, social and personal services"
          }
        ]
      }
    ],
    "title": "NHS Healthier You",
    "value": {
      "amount": 738000000,
      "currency": "GBP"
    },
    "status": "active",
    "coveredBy": [
      "GPA"
    ],
    "bidOpening": {
      "date": "2026-06-08T08:00:00+01:00"
    },
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "awardPeriod": {
      "startDate": "2026-06-08T08:00:00+01:00"
    },
    "description": "The Contracting Authority is procuring the NHS Healthier You Programme utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023. This competitive provider selection process has multiple gateways as described in this notice. <br/><br/>The NHS Healthier You Programme procurement comprises of the following:<br/>•\tNHS  Healthier You Behavioural Support for Obesity Prescribing (\"BSOP) Service\"): Targeted support for individuals prescribed pharmacotherapy GLP-1 medications as approved in a Primary Care setting by NICE. Service Users provided with the BSOP Service are referred to as the \"BSOP Cohort\".<br/>•\tNHS Healthier You Diabetes Prevention Programme (\"DPP Service\"): Support for individuals identified as at high risk of developing type 2 diabetes. Service Users provided with the DPP Service are referred to as the \"DPP Cohort\". <br/>•\tNHS Healthier You Type 2 Diabetes Path to Remission (\"T2DR Service\"): Support for individuals diagnosed with type 2 diabetes within the last 6 years and living with overweight or obesity. Service Users provided with the T2DR Service are referred to as the \"T2DR Cohort\".<br/>•\tNHS Healthier You Long Term Conditions Prevention Pilot (\"LTCP Service\"): Support for individuals diagnosed with hypertension. Service Users provided with the LTCP Service are referred to as the \"LTCP Cohort\".<br/><br/>The Contracting Authority has divided this opportunity into 26 ICB/ICB Clusters. ICB Clusters are groupings of ICBs. The complete list is set out in VI.3.<br/><br/>Bidders will need the capability and capacity to provide the full suite of services to an ICB/ICB Cluster, offering eligible participants a choice of group based in-person services or a digitally delivered, independently accessed service provided through a web browser or a mobile application. The Type 2 diabetes Path to Remission intervention will only be delivered on a one-to-one basis (delivered in-person or remotely).<br/><br/>Contracts will be awarded by Supplier. Bidders can be awarded a contract for more than one ICB/ICB Cluster. In such instances, one contract would be issued to the Supplier listing the ICB's/ICB Clusters awarded. This means a maximum of 26 contracts may be awarded in the event a different Supplier is awarded for each ICB/ICB Cluster.<br/><br/>The anticipated value across the ICB's/ICB Clusters is £386,000,000 excluding VAT. This is based on the initial term of 36 months. There will be an option to extend by up to 24 months, giving a maximum term of 60 months. The anticipated value of the 60 month term is £738,000,000 excluding VAT. VAT will be applied as appropriate.<br/><br/>The estimated date of mobilisation / service commencement will be from 1 November 2026.",
    "tenderPeriod": {
      "endDate": "2026-06-05T12:00:00+01:00"
    },
    "communication": {
      "atypicalToolUrl": "https://atamis-1928.my.site.com/s/Welcome"
    },
    "hasRecurrence": false,
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "bidValidityPeriod": {
        "durationInDays": 180
      }
    },
    "submissionMethod": [
      "electronicSubmission",
      "written"
    ],
    "procurementMethod": "open",
    "selectionCriteria": {
      "criteria": [
        {
          "type": "suitability",
          "appliesTo": [
            "supplier"
          ],
          "description": "Applicants will be assessed in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 on the basis of the information provided in response to the Basic Selection Criteria Questionnaire (assessment Stage 1)."
        },
        {
          "type": "economic",
          "appliesTo": [
            "supplier"
          ],
          "description": "Selection criteria as stated in the procurement documents."
        },
        {
          "type": "technical",
          "appliesTo": [
            "supplier"
          ],
          "description": "Selection criteria as stated in the procurement documents."
        }
      ]
    },
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "https://atamis-1928.my.site.com/s/Welcome",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-107961",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UK",
        "locality": "Leeds",
        "postalCode": "LS1 4AP",
        "countryName": "United Kingdom",
        "streetAddress": "7-8 Wellington Place"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "buyerProfile": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "url": "https://atamis-1928.my.site.com/s/Welcome",
        "name": "Leigh Parker",
        "email": "leigh.parker1@nhs.net"
      }
    },
    {
      "id": "GB-FTS-133554",
      "name": "Independent patient choice and procurement panel",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House"
      },
      "identifier": {
        "legalName": "Independent patient choice and procurement panel"
      }
    }
  ],
  "language": "en",
  "description": "There will be 26 ICB's/ICB Clusters available to Bid for under this procurement. This procurement is not structured as a lotted procurement. Bidders will be able to identify the ICB(s)/ICB Cluster(s) they wish to Bid for in the Form of Tender, relevant ICB/ICB Cluster Quality Envelope(s) and Commercial Schedule (Price Response).<br/><br/>Bidders can submit Bids, and be awarded contracts, for single or multiple ICB's/ICB Clusters. The 26 ICB's/ICB Clusters under this procurement are:<br/><br/>1. Central East<br/>2. Essex<br/>3. Norfolk and Suffolk<br/>4. West and North London<br/>5. Thames Valley<br/>6. Surrey and Sussex<br/>7. Hampshire and the Isle of Wight<br/>8. Leicester, Leicestershire and Rutland with Northamptonshire<br/>9. Derbyshire, with Nottinghamshire and Lincolnshire<br/>10. Birmingham and Solihull with Black Country<br/>11. Staffordshire and Stoke-on-Trent with Shropshire, Telford and Wrekin<br/>12. Coventry and Warwickshire, with Herefordshire and Worcestershire<br/>13. Cornwall and the Isles of Scilly with Devon<br/>14. Gloucestershire with Bristol, North Somerset and South Gloucestershire<br/>15. Dorset with Somerset and Bath, North East Somerset, Swindon and Wiltshire<br/>16. North East and North Cumbria<br/>17. Humber and North Yorkshire<br/>18. South Yorkshire<br/>19. West Yorkshire<br/>20. North East London<br/>21. South East London<br/>22. South West London<br/>23. Lancashire and South Cumbria<br/>24. Greater Manchester<br/>25. Cheshire and Merseyside<br/>26. Kent and Medway <br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award.",
  "initiationType": "tender"
}

{
  "id": "003389-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-01-15T10:48:26Z",
  "ocid": "ocds-h6vhtk-060669",
  "buyer": {
    "id": "GB-FTS-130973",
    "name": "NHS England"
  },
  "tender": {
    "id": "C362277",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "The planned procurement of NHS Healthier You will comprise:<br/><br/>Diabetes prevention: a 9-month behaviour support intervention for people at risk of type 2 diabetes. For more information visit: https://www.england.nhs.uk/diabetes/diabetes-prevention/<br/><br/>Behavioural support for obesity prescribing: a 9-month behaviour support intervention for people prescribed weight-loss medication in primary care. <br/>Type 2 diabetes path to remission: a 3-month total diet replacement intervention followed by a 9-month behaviour support intervention for people living with type 2 diabetes. For more information visit: https://www.england.nhs.uk/diabetes/treatment-care/diabetes-remission/<br/><br/>Long-term conditions prevention pilot: a pilot 9-month behaviour support intervention for people living with hypertension. This intervention will be piloted over 3 years in 8 ICB areas (to be confirmed) with an option to expand wider as evidence emerges.<br/><br/>Suppliers will need the capability and capacity to provide the full suite of services to an ICB or ICB cluster (or group of ICB’s), offering eligible participants a choice of group based on one to one based in-person services, group based remote services delivered via video conference, or a digitally delivered one to one or independently accessed service provided through a web browser or a mobile application. The Type 2 diabetes path to remission intervention will only be delivered on a one-to-one basis. Additional information: All information contained within this notice is still indicative and not yet confirmed.<br/><br/>Full details of the planned procurement will be finalised and released at Invitation to Tender (ITT) stage, which will be issued under a separate Contract Notice published via the Find a Tender service<br/><br/>Any questions in relation to this notice or planned procurement should be submitted via the Atamis portal. <br/><br/>If you have not already registered your interest in this planned procurement, please do so via the Atamis e-sourcing portal https://health-family.force.com/s/Welcome"
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "England"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ]
      }
    ],
    "title": "NHS Healthier You",
    "value": {
      "amount": 386000000,
      "currency": "GBP"
    },
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "Notification of Pre-Tender Briefing Session<br/><br/>NHS England (NHSE) wishes to notify interested providers of its intention to undertake a pre-tender briefing session in relation to the NHS Healthier You procurement, as outlined in the Planned Procurement Notice published on 05/12/25 (https://www.find-tender.service.gov.uk/Notice/079982-2025)<br/><br/>The planned procurement will seek to commission a range of behavioural support for obesity prescribing and diabetes prevention services, known as NHS Healthier You, through the competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023.<br/><br/>In order to assist potential Bidders prepare for the release of this planned procurement, NHSE will hold a Pre-Tender Briefing Session on Tuesday 3 February 2026 from 1:30-3:00pm.<br/><br/>The aim of this session is to:<br/>•\tProvide information to support potential Bidders to assess and plan bidding capacity, capability and resource<br/>•\tHelp potential Bidders navigate the bidding process, including how to submit a compliant bid, provide the correct documentation, and guidance on Atamis completion including uploading attachments<br/>•\tProvide potential Bidders with guidance on the new Social Value Model<br/><br/>Potential Bidders are asked to register their interest in attending this session through the Atamis e-sourcing portal https://health-family.force.com/s/Welcome by messaging the individuals name, email and job title via the portal by midday (12:00pm) on Monday 2 February 2026. <br/><br/>Registered attendees will be sent the session joining link via the Atamis portal messaging service shortly after this closing time. <br/><br/>Whilst attendees at the live session will be limited to 3 per organisation, the session will be recorded and released to all suppliers who have registered an interest in this planned procurement via the Atamis portal.",
    "communication": {
      "atypicalToolUrl": "https://atamis-1928.my.site.com/s/Welcome",
      "futureNoticeDate": "2026-03-02T00:00:00Z"
    },
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-130973",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKJ1",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "buyerProfile": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "name": "Suzanne Collar",
        "email": "suzanne.collar1@nhs.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}